Board-certified dermatologist Dr Stefanie Williams will host an Expert Clinic session at the Aesthetics Conference and Exhibition (ACE) on Saturday March 2, focusing on microneedling.
Global personal care company L’Oréal has released a prototype for the first wearable sensor and app to measure the skin’s pH levels for creating customised and personalised skincare regimes.
Pharmaceutical and skincare manufacturer, mesoestetic, has appointed aesthetic physician Dr Lori Nigro as its UK medical advisor and key opinion leader.
In September, Spanish pharmaceutical company Almirall acquired Allergan’s US medical dermatology unit portfolio by using a €400 million bridge loan. It acquired brands Aczone (dapsone), Tazorac (tazarotene), Azelex (azelaic acid) and Cordran Tape (fludroxycortide).
CEO and founder of EF MEDISPA, Esther Fieldgrass is now the host of a new podcast, called The Beauty Biz.
Data from the newly established UK skin cancer database has suggested that there are more than 350% more instances of cutaneous squamous cell carcinomas (cSCC) every year in England than previously thought.
Preliminary guidelines for the off-label use of calcium hydroxylapatite (CaHA) for biostimulation in the face and body has been published in Dermatologic Surgery.
The US Food and Drug Administration (FDA) has approved hyaluronic acid dermal filler Restylane Lyft for cheek augmentation and the correction of age-related mid-face contour deficiencies via small blunt tip cannula in patients over the age of 21.
A pharmacy that is ‘dedicated to private prescribers’ called Galenic Laboratories, trading as Roseway Labs, has launched into the aesthetic sector.
UK distributor Healthxchange Pharmacy has launched two Obagi Men kits. The kits, called ‘Leather’, which is more suited to normal/dry skin, and ‘Steel’, for normal/oily skin, aim to target ageing, provide hydration and to give protection, the company claims.